Scientists at acib and the University of Natural Resources Vienna develop world’s first continuous purification method for valuable drugs. This will lead to significantly reduced production costs and to cheaper pharmaceuticals that are affordable for non-privileged health care systems.
Imagine a dear relative suffering from cancer – and you could not afford a treatment because the drugs are too expensive. The Austrian Centre of Industrial Biotechnology (acib) developed a method with the power to reduce production costs of highly valued drugs significantly.
Without antibodies we would be at the mercy of pathogens or cancer cells. Therapeutic antibodies are used as passive vaccines, for cancer therapy or for controlling autoimmune diseases such as multiple sclerosis. According to “bccresearch.com” the global market for antibody drugs was worth nearly 70 billion USD in 2014 and should rise to 122 billion USD until 2019.
Two thirds of those molecules are produced biotechnologically using Chinese hamster ovary cells (CHO). Actually the major cost factor for industry is purification using “protein A” affinity chromatography where tens of thousands of liters of culture volume have to be processed annually. About 80 % of the production costs fall upon purification.
Here this new purification method comes into play. Researchers from the Austrian Centre of Industrial Biotechnology (acib) and the University of Natural Resources and Life Sciences Vienna (BOKU) developed the world’s first downstream processing method for recombinant antibodies from clarified CHO cultures. From a technical view, the purification method combines a Calcium-Phosphate flocculation with a subsequent cold ethanol precipitation in a tubular reactor realized as a double-pipe heat exchanger that is operated in counter-current flow.
A feasibility study exemplified by the purification of immune globulin G (IgG) shows that the continuous method can compete with “protein A” affinity chromatography in terms of yield and outperforms chromatography according to the speed of operation. A further advantage is that the operation parameters can be easily transferred from the actually used batch to the continuous approach. In combination with a prior concentration step the new method is perfect for purification of low titer supernatants. “Our method shows great potential as a new platform technology for the pharmaceutical industry”, says Prof. Alois Jungbauer, who is in negotiations with several international companies about building pilot plants.
Read more: First Method for Continuous Purification of Valuable Antibodies
The Latest on: Drug production
[google_news title=”” keyword=”Drug production” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug production
- AJ Brown Warns Will Levis Of NFL’s ‘Random’ Drug Testing Following His Viral Body Transformationon March 30, 2023 at 6:47 pm
AJ Brown has a warning for a soon-to-be rookie regarding the NFL‘s drug screening policy. The wideout sent a message to quarterback Will Levis, who’s going viral for his incredible body transformation ...
- DEA warns of dangerous 'tranq' drug's growing prevalence in Texason March 30, 2023 at 3:47 pm
The DEA is sending a public safety alert about the widespread threat of fentanyl being mixed with animal tranquillizer xylazine.
- High life: Alleged drug dealer hides from cop in plain sight in surreal photoon March 30, 2023 at 12:49 pm
Etmond Lika, 32, was wanted in connection with the production of a Class B drug, and he is currently sentenced to serve two years and four months in prison for his crime.
- Lupus drug development market heating up, while FDA links with advocacy group to further accelerate researchon March 30, 2023 at 11:31 am
The long-underserved systemic lupus erythematosus (SLE) market is suddenly buzzing with treatment possibilities. Less than two years after AstraZeneca’s approval for Saphnelo — the first new SLE drug ...
- FDA makes sales of opioid overdose treatment drug over-the-counteron March 30, 2023 at 5:41 am
The U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) sales status to Narcan, a move that health experts say could save lives.
- PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZINon March 30, 2023 at 1:03 am
TheracosBio recently received FDA approval for Brenzavvy™ (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitorPiramal supported TheracosBio with starting materials, active pharmac ...
- Oral Thin Film Drug Delivery & Manufacturing Market By 2031on March 29, 2023 at 8:49 pm
The "Oral Thin Film Drug Delivery and Manufacturing Market" Study Describes how the technology industry is evolving and ...
- Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)on March 29, 2023 at 1:59 am
Lonza increases capacity and capabilities in Visp (CH) with the completion of a new line for cGMP clinical and commercial drug product manufacturing The line is fully operational, and the first ...
- Ban on chemicals used in drug production to be tightened upon March 28, 2023 at 5:00 pm
The justice ministry is to tighten the ban on more than 100 chemicals used in the production of illegal drugs such as speed, crystal meth and XTC from the end of this week. At the moment prosecutors ...
- Weeding Out Employees: The Ups and Downs of Drug-Testing Manufacturing Workforceon March 28, 2023 at 4:20 pm
Finding and keeping dependable employees has always been a priority for employers. For manufacturers, drug testing is a tried-and-true method of weeding out employees who may be less dependable. Howev ...
via Bing News